Skip to main content

Health + Wellness

Three Case CCC Members to Play Pivotal Roles in Interdisciplinary Collaborative
A new $2 million grant from the Mt. Sinai Health Foundation has established the Mt. Sinai Fellows in Therapeutic Discovery, an effort to support the recruitment of exceptional mid-career MD/PhD researchers to participate in an interdisciplinary collaborative that includes CWRU's hospital…
Melissa Kline Named Glick Chair at CWRU School of Nursing
Professorship leverages power of nurses to lead healthcare As healthcare systems across the country feel the mounting pressures of an aging and increasingly diverse patient population, staff burnout, a workforce shortage and rising costs – a partnership between The MetroHealth System and Case…
CWRU Awarded $1.4 Million for Great Minds Fellowship Initiative
Case Western Reserve awarded $1.4 million for Ohio’s Great Minds Fellowship initiative Eligible students may receive up to $10,000 for pursuing careers in behavioral health As part of a statewide effort to encourage more students to pursue behavioral health-related professions, the Ohio…
CAAPP Featured on Sound of Ideas
Erika Trapl, PhD, Case CCC's Associate Director for Community Outreach and Engagement, Charles Modlin, MD, MBA, Director of the MetroHealth Minority Men's Health Institute, and Waverly Willis, owner/operator of two Urban Kutz barbershops and member of Case CCC's Community Advisory Board, discussed…
Joel%20Saltzman.jpeg
Saltzman Named ASCO Fellow
Joel Saltzman, MD, a member of Case CCC's Developmental Therapeutic Program and a clinician in the Department of Hematology and Oncology at Cleveland Clinic Taussig Cancer Institute, has been named a Fellow of the American Society of Clinical Oncology (FASCO). An ASCO member is recognized as a…
Cao%2C%20Kaixiang.jpg
Cao and Team Challenge Current Assumptions about Slowing Cancer Growth by Stopping Overexpression of LSD1 Proteins
Kaixiang Cao, PhD, a member of Case CCC's Cancer Genomics & Epigenomics program, is challenging the current paradigms for using the LSD1 (lysine-specific histone demethylase 1A) protein to slow cancer growth. He and his team posit that the entire LSD1 protein can be completely degraded rather…
Christine Horvat Davey Advises on Best Time to Take HIV Drugs
While there’s no cure for human immunodeficiency virus (HIV), there are measures people can take to avoid developing the disease. One involves taking drugs called preexposure prophylaxis (PrEP), which received Food and Drug Administration (FDA) approval in 2012. A newly released statement from…
Fabio-Cominelli-
Internationally recognized researcher Fabio Cominelli named a Distinguished University Professor
Fabio Cominelli’s contributions to groundbreaking research on gastrointestinal conditions, including Crohn’s disease and ulcerative colitis, has helped alleviate pain and complications for tens of millions of people worldwide living with these disorders. At Case Western Reserve University School…
mental-health-feat
Case Western Reserve awarded $1.4 million for Ohio’s Great Minds Fellowship initiative
Eligible students may receive up to $10,000 for pursuing careers in behavioral health As part of a statewide effort to encourage more students to pursue behavioral health-related professions, the Ohio Department of Higher Education has awarded Case Western Reserve University a $1.4 million…
169cancertarget.jpg
Case Western Reserve biochemists focus on degrading key cancer-driving protein; represents major shift in research
Case Western Reserve University biochemical researchers have identified a new function of a key protein that leads to cancer—a finding they believe could lead to more effective treatments for a range of cancers and other diseases. The protein is LSD1 (lysine-specific histone demethylase 1A), which…